References
Thachil J, Richards RM, Copeland G. Granulocytic sarcoma - a rare presentation of a breast lump. Ann R Coll Surg Engl. 2007;89:W7–W9.
Liu PI, Ishimaru T, McGregor DH, Okada H, Steer A. Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949–1969. Cancer. 1973;31:948–955.
Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981;48:1426–1437.
Guermazi A, Feger C, Rousselot P, Merad M, Benchaib N, Bourrier P, et al. Granulocytic sarcoma (chloroma): imaging findings in adults and children. AJR. American J Roentgenol. 2002;178:319–325.
Pui MH, Fletcher BD, Langston JW. Granulocytic sarcoma in childhood leukemia: imaging features. Radiology. 1994;190:698–702.
Guimarães MD, Marchiori E, Marom EM, Routbort MJ, Godoy MCB. Pulmonary granulocytic sarcoma (chloroma) mimicking an opportunistic infection in a patient with acute myeloid leukemia. Ann Hematol. 2013:10–11 (E-pub ahead of print).
Takasugi JE, Godwin JD, Marglin SI, Petersdorf SH. Intrathoracic granulocytic sarcomas. J Thorac Imaging. 1996;11:223–230.
Lee DA, Harris CP, Gresik VM, Rao P. Granulocytic sarcoma presenting as pneumonia in a child fluorescent in situ hybridization. J Pediatr Hematol Oncol. 2004;26:431–434.
Menasce LP, Banerjee SS, Beckett E, Harris M. Extramedullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathol. 1999;34:391–398.
References
Paget-Brown A, Kattwinkel J, Rodgers BM, Michalsky MP. The use of octreotide to treat congenital chylothorax. J Pediatr Surg. 2006;41:845–847.
Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone iodine (Betadine). Arch Dis Child Fetal Neonatal Ed. 2003;88:F531–F533.
Büttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest. 1999;116:682–687.
Shah D, Sinn JK. Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series. Acta Paediatr. 2012;101:e151–e155.
Greenough A. Pleural effusions. In: Greenough A and Milner AD, editors. Neontal Respiratoty Disorders. 2nd ed. London: Arnold Publication 2003.p. 355–364.
Matsukuma E, Aoki Y, Sakai M, Kawamoto N, Watanabe H, Iwagaki S, et al. Treatment with OK-432 for persistent congenital chylothorax in newborn infants resistant to octreotide. J Pediatr Surg. 2009;44:e37–e39.
Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev. 2010;9:CD006388.
Cormack BE, Wilson NJ, Finucane K, West TM. Use of Monogen for pediatric postoperative chylothorax. Ann Thorac Surg. 2004;77:301–305.
Chan GM, Lechtenberg E. The use of fat-free human milk in infants with chylous pleural effusion. J Perinatol. 2007;27:434–436.
References
Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85:421–426.
Mashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr.1997;130:352–357.
Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–276.
Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776–1780.
Pal P, Giri PP. Orange-brown chromonychia, a novel finding in Kawasaki disease. Rheumatol Int. 2013;33: 1207–1209.
Wright, DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulse doses of corticosteroids. J Pediatr. 1996;128:146–149.
Kuzmanova SI. The macrophage activation syndrome: a new entity, a potentially fatal complication of rheumatic disorders. Folia Med (Plovdiv). 2005;47:21–25.
Ramanan AV, Schneider R. Macrophage activation syndrome - what’s in a name! J Rheumatol. 2003;30:2513–2516.
Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85:421–426.
Muise A, Tallett SE, Silverman ED. Are children with kawasaki disease and prolonged fever at risk for macrophage activation syndrome? Pediatrics. 2003;6: e495–e496.
Latino GA, Manlhiot C, Yeung RS, Chahal N, McCrindle BW. Macrophage activation syndrome in the acute phase of Kawasaki disease. J Pediatr Hematol Oncol. 2010;32:527–531.
Servel AC, Vincenti M, Darras JP, Lalande M, Rodière M, Filleron A. Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis. Arch Pediatr. 2012;19:741–744.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Thawani, R., Chichra, A., Mahajan, A. et al. Case Reports. Indian Pediatr 51, 145–149 (2014). https://doi.org/10.1007/s13312-014-0332-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-014-0332-0